Results
|
101.
|
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver. [electronic resource] by
- Said, Rabih
- Kurzrock, Razelle
- Naing, Aung
- Hong, David S
- Fu, Siqing
- Piha-Paul, Sarina A
- Wheler, Jennifer J
- Janku, Filip
- Kee, Bryan K
- Bidyasar, Savita
- Lim, Joann
- Wallace, Michael
- Tsimberidou, Apostolia M
Producer: 20160512
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
102.
|
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trials. [electronic resource] by
- Janku, Filip
- Wheler, Jennifer J
- Naing, Aung
- Falchook, Gerald S
- Hong, David S
- Stepanek, Vanda M
- Fu, Siqing
- Piha-Paul, Sarina A
- Lee, J Jack
- Luthra, Rajyalakshmi
- Tsimberidou, Apostolia M
- Kurzrock, Razelle
Producer: 20130227
In:
Cancer research vol. 73
Availability: No items available.
|
|
103.
|
Phase I clinical trial of lenalidomide in combination with sorafenib in patients with advanced cancer. [electronic resource] by
- Ganesan, Prasanth
- Piha-Paul, Sarina
- Naing, Aung
- Falchook, Gerald
- Wheler, Jennifer
- Fu, Siqing
- Hong, David S
- Kurzrock, Razelle
- Janku, Filip
- Laday, Shell
- Bedikian, Agop Y
- Kies, Merrill
- Wolff, Robert A
- Tsimberidou, Apostolia M
Producer: 20141112
In:
Investigational new drugs vol. 32
Availability: No items available.
|
|
104.
|
Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program. [electronic resource] by
- Hou, Ming-Mo
- Liu, Xiaochun
- Wheler, Jennifer
- Naing, Aung
- Hong, David
- Bodurka, Diane
- Schmeler, Kathleen
- Tsimberidou, Apostolia
- Janku, Filip
- Zinner, Ralph
- Piha-Paul, Sarina
- Hu, Chung-Yuan
- Lu, Karen
- Kurzrock, Razelle
- Fu, Siqing
Producer: 20140623
In:
Anticancer research vol. 34
Availability: No items available.
|
|
105.
|
A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer. [electronic resource] by
- Patnaik, Amita
- Gordon, Michael
- Tsai, Frank
- Papadopoulos, Kyriakos P
- Rasco, Drew
- Beeram, Muralidhar
- Fu, Siqing
- Janku, Filip
- Hynes, Scott M
- Gundala, Sushma R
- Willard, Melinda D
- Zhang, Wei
- Lin, Aimee Bence
- Hong, David
Producer: 20190809
In:
Cancer chemotherapy and pharmacology vol. 82
Availability: No items available.
|
|
106.
|
Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer. [electronic resource] by
- Patnaik, Amita
- Gordon, Michael
- Tsai, Frank
- Papadopoulos, Kyriakos P
- Rasco, Drew
- Beeram, Muralidhar
- Fu, Siqing
- Janku, Filip
- Hynes, Scott M
- Gundala, Sushma R
- Willard, Melinda D
- Zhang, Wei
- Lin, Aimee Bence
- Hong, David
Publication details: Cancer chemotherapy and pharmacology 09 2018
In:
Cancer chemotherapy and pharmacology vol. 82
Availability: No items available.
|
|
107.
|
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study. [electronic resource] by
- Hong, David S
- Hui, David
- Bruera, Eduardo
- Janku, Filip
- Naing, Aung
- Falchook, Gerald S
- Piha-Paul, Sarina
- Wheler, Jennifer J
- Fu, Siqing
- Tsimberidou, Apostolia M
- Stecher, Michael
- Mohanty, Prasant
- Simard, John
- Kurzrock, Razelle
Producer: 20140623
In:
The Lancet. Oncology vol. 15
Availability: No items available.
|
|
108.
|
Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial. [electronic resource] by
- Subbiah, Vivek
- Dumbrava, Ecaterina Ileana
- Jiang, Yunfang
- Thein, Kyaw Z
- Naing, Aung
- Hong, David S
- Fu, Siqing
- Piha-Paul, Sarina A
- Tsimberidou, Apostolia M
- Janku, Filip
- Meric-Bernstam, Funda
- Kurzrock, Razelle
- Falchook, Gerald
Publication details: Experimental hematology & oncology 2020
In:
Experimental hematology & oncology vol. 9
Availability: No items available.
|
|
109.
|
Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors. [electronic resource] by
- Falchook, Gerald S
- Wheler, Jennifer J
- Naing, Aung
- Piha-Paul, Sarina A
- Fu, Siqing
- Tsimberidou, Apostolia M
- Hong, David S
- Janku, Filip
- Zinner, Ralph
- Jiang, Yunfang
- Huang, Mei
- Lin, Quan
- Parkhurst, Kristin
- Kurzrock, Razelle
Producer: 20150918
In:
Investigational new drugs vol. 33
Availability: No items available.
|
|
110.
|
BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease. [electronic resource] by
- Janku, Filip
- Vibat, Cecile Rose T
- Kosco, Karena
- Holley, Veronica R
- Cabrilo, Goran
- Meric-Bernstam, Funda
- Stepanek, Vanda M
- Lin, Patrick P
- Leppin, Lorieta
- Hassaine, Latifa
- Poole, Jason C
- Kurzrock, Razelle
- Erlander, Mark G
Producer: 20150422
In:
Oncotarget vol. 5
Availability: No items available.
|
|
111.
|
Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trials. [electronic resource] by
- Subbiah, Ishwaria M
- Falchook, Gerald S
- Kaseb, Ahmed O
- Hess, Kenneth R
- Tsimberidou, Apostolia M
- Fu, Siqing
- Subbiah, Vivek
- Hong, David S
- Naing, Aung
- Piha-Paul, Sarina A
- Akmal, Owais
- Janku, Filip
- Kurzrock, Razelle
Producer: 20160802
In:
Oncotarget vol. 6
Availability: No items available.
|
|
112.
|
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine. [electronic resource] by
- Tsimberidou, Apostolia-Maria
- Hong, David S
- Wheler, Jennifer J
- Falchook, Gerald S
- Janku, Filip
- Naing, Aung
- Fu, Siqing
- Piha-Paul, Sarina
- Cartwright, Carrie
- Broaddus, Russell R
- Nogueras Gonzalez, Graciela M
- Hwu, Patrick
- Kurzrock, Razelle
Producer: 20200706
In:
Journal of hematology & oncology vol. 12
Availability: No items available.
|
|
113.
|
Prevalence of MDM2 amplification and coalterations in 523 advanced cancer patients in the MD Anderson phase 1 clinic. [electronic resource] by
- Dembla, Vikas
- Somaiah, Neeta
- Barata, Pedro
- Hess, Kenneth
- Fu, Siqing
- Janku, Filip
- Karp, Daniel D
- Naing, Aung
- Piha-Paul, Sarina Anne
- Subbiah, Vivek
- Tsimberidou, Apostolia M
- Shaw, Kenna
- Meric-Bernstam, Funda
- Hong, David S
Publication details: Oncotarget Sep 2018
In:
Oncotarget vol. 9
Availability: No items available.
|
|
114.
|
Molecular characterization of gallbladder cancer using somatic mutation profiling. [electronic resource] by
- Javle, Milind
- Rashid, Asif
- Churi, Chaitanya
- Kar, Siddhartha
- Zuo, Mingxin
- Eterovic, Agda Karina
- Nogueras-Gonzalez, Graciela M
- Janku, Filip
- Shroff, Rachna T
- Aloia, Thomas A
- Vauthey, Jean-Nicholas
- Curley, Steven
- Mills, Gordon
- Roa, Ivan
Producer: 20140512
In:
Human pathology vol. 45
Availability: No items available.
|
|
115.
|
Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies. [electronic resource] by
- Wang, Yudong
- Janku, Filip
- Piha-Paul, Sarina
- Hess, Kenneth
- Broaddus, Russell
- Liu, Lidong
- Shi, Naiyi
- Overman, Michael
- Kopetz, Scott
- Subbiah, Vivek
- Naing, Aung
- Hong, David
- Tsimberidou, Apostolia M
- Karp, Daniel
- Yao, James
- Fu, Siqing
Producer: 20201112
In:
Scientific reports vol. 10
Availability: No items available.
|
|
116.
|
Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative. [electronic resource] by
- Tsimberidou, Apostolia-Maria
- Iskander, Nancy G
- Hong, David S
- Wheler, Jennifer J
- Falchook, Gerald S
- Fu, Siqing
- Piha-Paul, Sarina
- Naing, Aung
- Janku, Filip
- Luthra, Rajyalakshmi
- Ye, Yang
- Wen, Sijin
- Berry, Donald
- Kurzrock, Razelle
Producer: 20130426
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
117.
|
A first-in-human study of AMG 208, an oral MET inhibitor, in adult patients with advanced solid tumors. [electronic resource] by
- Hong, David S
- Rosen, Peter
- Lockhart, A Craig
- Fu, Siqing
- Janku, Filip
- Kurzrock, Razelle
- Khan, Rabia
- Amore, Benny
- Caudillo, Isaac
- Deng, Hongjie
- Hwang, Yuying C
- Loberg, Robert
- Ngarmchamnanrith, Gataree
- Beaupre, Darrin M
- Lee, Peter
Producer: 20160531
In:
Oncotarget vol. 6
Availability: No items available.
|
|
118.
|
FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. [electronic resource] by
- Jardim, Denis L
- Wheler, Jennifer J
- Hess, Kenneth
- Tsimberidou, Apostolia M
- Zinner, Ralph
- Janku, Filip
- Subbiah, Vivek
- Naing, Aung
- Piha-Paul, Sarina A
- Westin, Shannon N
- Roy-Chowdhuri, Sinchita
- Meric-Bernstam, Funda
- Hong, David S
Producer: 20141014
In:
PloS one vol. 9
Availability: No items available.
|
|
119.
|
Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience. [electronic resource] by
- Fu, Siqing
- Shi, Naiyi
- Wheler, Jennifer
- Naing, Aung
- Janku, Filip
- Piha-Paul, Sarina
- Gong, Jing
- Hong, David
- Tsimberidou, Apostolia
- Zinner, Ralph
- Subbiah, Vivek
- Hou, Ming-Mo
- Ramirez, Pedro
- Ramondetta, Lois
- Lu, Karen
- Meric-Bernstam, Funda
Producer: 20160527
In:
Gynecologic oncology research and practice vol. 2
Availability: No items available.
|
|
120.
|
HER2/neu-directed therapy for biliary tract cancer. [electronic resource] by
- Javle, Milind
- Churi, Chaitanya
- Kang, HyunSeon C
- Shroff, Rachna
- Janku, Filip
- Surapaneni, Rakesh
- Zuo, Mingxin
- Barrera, Christian
- Alshamsi, Humaid
- Krishnan, Sunil
- Mishra, Lopa
- Wolff, Robert A
- Kaseb, Ahmed O
- Thomas, Melanie B
- Siegel, Abby B
Producer: 20160324
In:
Journal of hematology & oncology vol. 8
Availability: No items available.
|